Talcum Powder Lawsuits Bring Talc Cancer Link to the Fore
When Jackie Fox's baby powder lawsuit verdict hit the mainsteam media, American women were forced to reevaluate their understanding of the ovarian cancer risks posed by talcum powder.
Friday, March 11, 2016 - Researchers have debated the potential link between women's use of talcum powder and ovarian cancer development since the 1970s. Now, following the February announcement of a $72 million baby powder cancer lawsuit verdict, concerned women and family members have taken up the debate.
Research conducted over the past four decades indicates that women who use talc products such as Johnson's Baby Powder or Shower to Shower face higher rates of ovarian cancer. Researchers in separate talcum powder ovarian cancer studies have concluded that using baby powder that contains talc increases the risk of ovarian cancer anywhere from 33% to 90%, with most estimates settling around 33-41%. Yet despite this information, published in peer-reviewed medical journals and originating from epidemiology practitioners and ovarian cancer specialists representing leading medical institutions such as Brigham and Women's Hospital and the Harvard School of Medicine, Johnson & Johnson officials persist in denying the connection between baby powder and ovarian cancer.
In the recent St. Louis baby powder cancer lawsuit, jurors found J&J guilty of a conspiracy charge, confirming that company officials have actively sought to conceal talcum powder cancer warning information from the public. Company officials reportedly funded a talcum powder task force, which was convened in the 1990s in an effort to counter talcum powder cancer research emerging at the time. The Task Force was to protect the interests of talcum powder producers at all costs, aiming to keep vital baby powder ovarian cancer information away from the eyes of consumers. The company engaged in multiple advertising campaigns, some of which specifically targeted Black and Latina women, reinforcing the idea that talcum powder products like Johnson's Baby Powder and Shower to Shower were safe for routine and even daily use.
Inundated by media campaigns urging women to use Johnsons baby powder daily – "A sprinkle a day keeps the odor away" – for dusting the genital area, many women have assumed talcum powder is as harmless as the name implies. Baby powder, gentle enough for babies. And for decades, Johnson & Johnson has cultivated its brand as synonymous with safe, gentle, and dependable – a family name. It is taking a significant shift in mindset for the American public to come to terms with the reality of talcum powder dangers – that a product we though was innocuous, called Baby Powder of all things, actually causes a deadly form of cancer.
Ovarian cancer, if caught early, is a relatively treatable form of cancer. The problem is that early stages of ovarian cancer rarely have telltale signs. Some pelvic pain, perhaps, but most women experience menstrual cramps, painful ovulation, and various other twinges from time to time. A bit of pelvic pain, or pain during sex or urination, is not going to send most women to the doctor seeking a diagnosis. When ovarian cancer symptoms become more severe and readily detectable, in the disease's later stages, it becomes more difficult to treat, sometimes having spread throughout the pelvic region by this time. Due to this fact, the idea that a company would knowingly conceal baby powder cancer information from consumers, and in fact launch advertising to encourage the specific use of talcum powder that caused ovarian cancer, is egregious. As women and their families come to terms with the reality of the talcum powder ovarian cancer danger, they are rightfully stunned and outraged.
Even today, following the unequivocal baby powder ovarian cancer lawsuit verdict handed down from a St. Louis jury, J&J officials persist in claiming talcum powder cancer claims are false. Having examined each study and every bit of internal J&J correspondence on the subject of talcum powder cancer and baby powder marketing to women, a majority of the jury strongly agreed that J&J was guilty of fraud, negligence and conspiracy related to Ms. Fox's baby powder cancer claims. The plaintiff was awarded a combined $72 million and actual and punitive baby powder cancer damages.
No-Cost, No-Obligation Baby Powder Cancer Lawsuit Case Review for Women and Families of Women Who Were Diagnosed with Ovarian Cancer and Have a History of Using Talcum Powder
The Onder Law Firm
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation. For more information, visit Talcum Powder Cancer Lawsuit Center or call 1-877-ONDER-LAW.